TrialJCO precision oncology2022

Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.

Jacob E Berchuck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.